NCT00122954View on ClinicalTrials.gov

Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Multiple SclerosisDepression
Interventions
DRUG

Fish oil concentrate

fish oil concentrate at a daily dose of 6 grams (2.1 gram EPA and 1.5 gram DHA).

DRUG

Placebo

soybean oil with 1% fish oil at a daily dose of 6 grams

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Oregon Health and Science University

OTHER

NCT00122954 - Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter